Deadline: 4 December 2017
The United Nations Office for Project Services (UNOPS) through the Global Drug Facility (GDF) is seeking proposals from qualified organizations to develop and implement a plan that will catalyse the use of paediatric formulations of second-line drugs to treat drug-resistant TB.
The objective of this CFP is to identify an organization with a proven track record working in paediatric TB, particularly MDR-TB, which can identify and coordinate early adopter programmes to catalyse the use of these new formulations, particularly from a procurement and supply chain management perspective.
Grant Information
Grant Proposals must not exceed USD 215, 000, any amount over the ceiling must be co-financed by the selected organization.
Eligibility Criteria
The minimum eligibility criteria are:
- Not-for-profit international or national non-governmental organizations.
- Demonstrated experience and expertise in:
- Clinical management of children with drug-resistant TB;
- Proven experience in facilitating introduction of new tools for the diagnosis, prevention and/or treatment of TB;
- Experience in coordinating stakeholder meetings that result in clear, concise, action-oriented outcomes.
- Presence and/or network to carry out the project activities in multiple countries, as needed
- Good relationships with key stakeholders in the TB space, including but not limited to delivery agencies, funders, manufacturers, normative agencies, and regulatory bodies.
- Administrative, financial, and technical capacity to carry out the project activities within the time frame required.
How to Apply
Applications must be submitted via email at the address given on the website.
For more information, please visit Call for Proposals.
